PD-1+ CD4 T cells showed a similar trend but did not reach statistical significance.
← all excerpts
Targeting Tyro3, Axl, and MerTK Receptor Tyrosine Kinases Significantly Sensitizes Triple-Negative Breast Cancer to CDK4/6 Inhibition.
1
—
—
PD-1+ CD4 T cells showed a similar trend but did not reach statistical significance.